Oct 22, 2012
Everyone is invited to “Get to Know The University of Arizona Arthritis Center,” the annual fall luncheon of The University of Arizona Arthritis Center Friends, on Thursday, Nov. 1, 11:30 a.m. to 1:30 p.m., at Skyline Country Club, 5200 E. St. Andrews Drive, Tucson.
Eric P. Gall, MD, interim director and one of the founders of The University of Arizona Arthritis Center, will deliver the keynote address, “Research at The University of Arizona Arthritis Center,” at 12:45 p.m.
The center is a clinical and basic research leader with a focus on identifying the causes of arthritis and developing improved diagnosis, measurement and treatment of the many forms of the disease that affect millions.
Dr. Gall’s own research interests include new treatments for arthritis; the development of arthritis, metabolic bone disease and hemophilic arthritis (arthritis in hemophiliacs); and diseases with abnormal collagen that result in hypermobility (joint movement beyond the normal range of motion). He serves as an expert consultant on hypermobility disorders, such as Ehlers Danlos Syndrome.
Tickets are $30 for The University of Arizona Arthritis Center Friends members; $35 for non-members. Reservations are requested by Friday, Oct. 26, payment may be made at the door. (PLEASE NOTE: tickets may not be purchased at the door.) To reserve tickets, please call The University of Arizona Arthritis Center Friends, 520-626-7901.
The University of Arizona Arthritis Center Friends support the Center’s mission to help create a world free of arthritis and autoimmune diseases. Friends members are invited to participate in ongoing programs and special events designed to increase awareness and promote optimal health for arthritis sufferers.
The University of Arizona Arthritis Center, a Center of Excellence at the UA College of Medicine – Tucson, strives to improve the lives of millions afflicted with one of the many forms of arthritis. The center conducts both clinical and basic research and educates health-care providers and scientists in the development of more effective therapies. The goal of the research is to change the way patients are treated globally. The knowledge gained from this research will develop and test more effective therapies with the hope of reversing the disease process. Currently, more than 20 research studies are being conducted at the center. For more information, please visit the website www.arthritis.arizona.edu